Experience

Zacco - 360° Intellectual Property

• Denmark
• Legal Services
• 200 - 300 Employee

• Partner, European Patent Attorney

  • Jan 2022 - Present



Chas. Hude A/S

• Biotechnology Research
• 1 - 100 Employee

• Senior Partner, CEO

  • Dec 2019 - Nov 2021

  Patent consulting Patent consulting



Novo Nordisk A/S

• Copenhagen

• Principal Patent Attorney

  • Jan 2015 - Nov 2019

  Principal Patent Attorney in Diabetes Patents, Pharma Patents I and Pharma Patents II responsible for patent matters for the products Tresiba®, Xultophy®, Ryzodeg® and NovoMix®. Further responsible for a number of R&D projects on DNA vaccines and stem cell based product candidates, gene therapy, technology projects, training of junior attorneys and being the expert responsible for global Patent Term Extension matters. Principal Patent Attorney in Diabetes Patents, Pharma Patents I and Pharma Patents II responsible for patent matters for the products Tresiba®, Xultophy®, Ryzodeg® and NovoMix®. Further responsible for a number of R&D projects on DNA vaccines and stem cell based product candidates, gene therapy, technology projects, training of junior attorneys and being the expert responsible for global Patent Term Extension matters.



SB Patents ApS

• Søllerød, Copenhagen

• European Patent Attorney, Partner

  • Mar 2012 - Nov 2019

  Patent and business consulting firm providing business based patent consulting. Our focus is on bringing client value, using only experienced consultant having the combination of strong educational background, strong industrial background and patent firm experience. Products and services range from patent litigation to patent drafting as well as from strategy to practical execution. As a small exquisite consulting firm we provide focus, flexibility, client service, confidentiality and loyalty to our clients business. Show less



LEO Pharma

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of Patents

  • Jun 2009 - Jan 2012

  Heading the patent department including 10 people responsible for all patent related activities within LEO Pharma, e.g. advising organization on patents, new patent filings, competitor surveillance, freedom to operate analyses, oppositions, litigations in EU, CN and US para-IV, citizen´s petitions and discovery activities. Direct budget responsibility of 10M EUR. Heading the patent department including 10 people responsible for all patent related activities within LEO Pharma, e.g. advising organization on patents, new patent filings, competitor surveillance, freedom to operate analyses, oppositions, litigations in EU, CN and US para-IV, citizen´s petitions and discovery activities. Direct budget responsibility of 10M EUR.



Zacco - 360° Intellectual Property

• Denmark
• Legal Services
• 200 - 300 Employee

• European Patent Attorney, Partner

  • Jun 2005 - May 2009

  Consulting within the Chemistry/Biotech group as key account manager for a number of pharma and food companies. Tasks included e.g. FTO analyses, patent strategy, patent drafting and prosecution, oppositions, appeals, reexams, Danish pharma litigation as well as work-flow optimization and training of new patent attorneys. Consulting within the Chemistry/Biotech group as key account manager for a number of pharma and food companies. Tasks included e.g. FTO analyses, patent strategy, patent drafting and prosecution, oppositions, appeals, reexams, Danish pharma litigation as well as work-flow optimization and training of new patent attorneys.



Novo Nordisk

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Patent attorney, Research scientist

  • Feb 1995 - May 2005

  From 2001 to 2005 : Patent attorney within Corporate Patents. Responsibility for all patent activities for a number of Discovery and Development projects (incl liraglutide/Victoza(R) and semaglutide/Ozempic(R)/Rhybelsus(R)) as well as strategy projects. From 1995 to 2001 : Research scientist and project manager within CMC development of therapeutic peptides (insulin, insulin detemir/Levemir(R), insulin aspart/NovoRapid(R) and liraglutide/Victoza(R)). From 2001 to 2005 : Patent attorney within Corporate Patents. Responsibility for all patent activities for a number of Discovery and Development projects (incl liraglutide/Victoza(R) and semaglutide/Ozempic(R)/Rhybelsus(R)) as well as strategy projects. From 1995 to 2001 : Research scientist and project manager within CMC development of therapeutic peptides (insulin, insulin detemir/Levemir(R), insulin aspart/NovoRapid(R) and liraglutide/Victoza(R)).



Chr. Hansen

• Denmark
• Biotechnology Research
• 700 & Above Employee

• Research scientist

  • Sep 1992 - Jan 1995

  Position as research scientist within the Fermentation department in R&D. Responsibilities for development projects linked to the Technical University of Denmark. Position as research scientist within the Fermentation department in R&D. Responsibilities for development projects linked to the Technical University of Denmark.